Physician profile
David Dimenna
NPI 1659312395
$1,354.74
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $596 · 2020: $221 · 2021: $471 · 2022: $33.51 · 2023: $32.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $292.29 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $178.72 | 2020-2022 | |
| Melinta Therapeutics, LLC | $145.33 | 2019-2021 | |
| Smith+Nephew, INC. | $128.47 | 2019-2023 | Collagenase Santyl, Regranex |
| Sandoz INC. | $66.17 | 2019 | |
| Horizon Therapeutics Plc | $61.32 | 2020-2021 | |
| Stryker Corporation | $53.50 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $49.24 | 2019-2020 | |
| Bioventus LLC | $46.99 | 2019 | |
| Nabriva Therapeutics, Plc | $42.92 | 2020-2021 | |
| Zyla Life Sciences, INC. | $35.76 | 2019 | |
| Depuy Synthes Sales INC. | $33.89 | 2019 | |
| Journey Medical Corporation | $24.94 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $23.28 | 2019 | |
| Integra Lifesciences Corporation | $23.22 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $21.21 | 2020 | |
| Biotissue Holdings INC. | $20.32 | 2021 | |
| Linvatec Corporation | $17.13 | 2020 | |
| Kci USA, INC. | $16.75 | 2021 | |
| Boston Scientific Corporation | $15.11 | 2020 | |
| Alfasigma USA, INC. | $14.14 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.73 | 2019 | |
| Grt US Holding, INC. | $11.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dimenna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.